Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Kinas nationale undersøgelse af adrenal venøs prøvetagning (CNAVS)

11. november 2026 opdateret af: Xiongjing Jiang, Chinese Academy of Medical Sciences, Fuwai Hospital

En national multicenterundersøgelse af adrenal venøs prøvetagning til subtypediagnose af primær aldosteronisme i Kina

This multicenter study intends to combine retrospective analysis and prospective registry to evaluate the success rate and safety of adrenal venous sampling (AVS) via antecubital and femoral approach for patients with primary aldosteronism. The consistency of AVS with pathological results and clinical outcomes, the factors affecting the success of AVS, and the optimal population for AVS will be aslo analyzed in this study.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, and its most common subtypes are aldosterone-producing adenoma and idiopathic hyperaldosteronism, which account for 95% to 98% of PA. Subtype diagnosis is crucial for the treatment of primary aldosteronism, which conducts the appropriate treatment strategy. Currently, adrenal venous sampling (AVS) serves as the gold standard for subtyping of PA. How to improve the success rate of AVS has been a hot topic in the field of primary aldosteronism. This multicenter registry study intends to combine retrospective analysis and prospective registry to evaluate the success rate and safety of AVS via antecubital and femoral approach for patients with primary aldosteronism. The consistency of AVS with pathological results and clinical outcomes, the factors affecting the success of AVS, and the optimal population for AVS will be also analyzed in this study.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

1500

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Beijing Municipality
      • Beijing, Beijing Municipality, Kina, 100034
      • Beijing, Beijing Municipality, Kina, 100029
        • China-Japan Friendship Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Wuqiang Che, MD
      • Beijing, Beijing Municipality, Kina, 100037
        • Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
        • Ledende efterforsker:
          • Hui Dong, MD
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Xiongjing Jiang, MD
      • Beijing, Beijing Municipality, Kina, 100022
        • Chuiyangliu Hospital affiliated to Tsinghua University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Lin Pi, MD
      • Beijing, Beijing Municipality, Kina, 101100
        • Beijing Luhe Hospital, Capital Medical University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Dong Zhao, MD,PHD
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Kina, 401147
        • Chongqing General Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Rui He, MM
      • Chongqing, Chongqing Municipality, Kina, 400000
        • The First Affiliated Hospital of Chongqing Medical University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Dongying Zhang, MD
      • Chongqing, Chongqing Municipality, Kina, 404100
        • People's Hospital Affiliated to ChongqingThree Gorges Medical college
        • Kontakt:
        • Ledende efterforsker:
          • Xianhu Luo, MD
    • Fujian
      • Xiamen, Fujian, Kina, 361016
        • Cardiovascular Hospital Xiamen University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Tao Ye, MD
    • Gansu
      • Lanzhou, Gansu, Kina, 730000
        • Lanzhou University Second Hospital
        • Kontakt:
        • Kontakt:
          • Heng Yu
        • Ledende efterforsker:
          • Wei Liang, MD
    • Guangdong
      • Foshan, Guangdong, Kina, 528211
        • The Forth People's Hosptal of Nanhai District of Foshan City
        • Kontakt:
        • Ledende efterforsker:
          • Yayan Han, MD
      • Guangzhou, Guangdong, Kina, 510080
        • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
        • Ledende efterforsker:
          • Yingqing Feng, MD
        • Kontakt:
        • Kontakt:
      • Shenzhen, Guangdong, Kina, 518112
        • Shenzhen Third People's Hospital,Shenzhen, Guangdong Province 518112, China
        • Kontakt:
        • Ledende efterforsker:
          • Zhenzhong Zheng, MD,PHD
      • Shenzhen, Guangdong, Kina, 518116
        • Shenzhen Dapeng New District Kuiyong People's Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Tongqing Lu, MD
    • Guangxi
      • Nanning, Guangxi, Kina, 530000
        • The First Affiliated Hospital of Guangxi Medical University
        • Kontakt:
        • Kontakt:
          • Jianling LI
        • Ledende efterforsker:
          • Jiangnan Huang, MD
      • Nanning, Guangxi, Kina, 547000
        • Nanning Third People's Hospital
        • Kontakt:
          • Yongqi Xiao, MS
          • Telefonnummer: 86-07713394390
        • Kontakt:
        • Ledende efterforsker:
          • Yongqi Xiao, MS
    • Guizhou
      • Kaili, Guizhou, Kina, 556000
        • The Second Affiliated Hospital Of Guizhou Medical University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Yumei Xiang, MD
    • Hebei
      • Tangshan, Hebei, Kina, 063000
        • Tangshan hongci Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Guijuan Zhang, MD
    • Heilongjiang
      • Harbin, Heilongjiang, Kina, 150001
        • The First Affiliated Hospital of Harbin Medical University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Dechao Zhao, MD
    • Henan
      • Zhengzhou, Henan, Kina, 450003
        • Henan Provincial People's Hospital
        • Ledende efterforsker:
          • Min Liu, MD
        • Kontakt:
        • Kontakt:
      • Zhengzhou, Henan, Kina, 450000
        • Fuwai Central China Cardiovascular Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Qiuping Zhao, PhD
      • Zhengzhou, Henan, Kina, 450007
        • Zhengzhou Central Hospital Affiliated to Zhengzhou University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Shuhua Yu, MM
      • Zhengzhou, Henan, Kina, 450018
        • Zhengzhou Yihe Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Liang An, BD
      • Zhoukou, Henan, Kina, 466000
        • Zhoukou Central Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Baogong Wang, MD
    • Hubei
      • Wuhan, Hubei, Kina, 430060
        • Renmin Hospital of Wuhan University
        • Kontakt:
        • Ledende efterforsker:
          • Hongxin Xu, MD
      • Xiangyang, Hubei, Kina, 441021
        • Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
        • Kontakt:
        • Kontakt:
          • Luhong Li
        • Ledende efterforsker:
          • Qing'an Li
      • Yichang, Hubei, Kina, 443000
        • Yichang Central People's Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Yunbo Lv, MD
    • Jiangxi
      • Nanchang, Jiangxi, Kina, 330006
        • Second Affiliated Hospital of Nanchang University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Yifei Dong, MD,PhD
      • Nanchang, Jiangxi, Kina, 330038
        • Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
        • Kontakt:
          • Haohang Ruan, MBBS
          • Telefonnummer: 86-0791-87721036
        • Kontakt:
        • Ledende efterforsker:
          • Haohang Ruan, MBBS
    • Jilin
      • Changchun, Jilin, Kina, 130051
        • Jilin Province FAW General ospital
        • Kontakt:
        • Ledende efterforsker:
          • Wenhai Wang, MM
    • Liaoning
      • Dalian, Liaoning, Kina, 116011
        • Frist Aiffiliated Hospital of Dalian Medical University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Yinong Jiang, MD
    • Ningxia
      • Yinchuan, Ningxia, Kina, 750000
        • The First People's Hospital of Yinchuan
        • Kontakt:
        • Kontakt:
          • Yunhai Ma
        • Ledende efterforsker:
          • Fang Chen, PD
    • Qinghai
      • Xining, Qinghai, Kina, 810000
        • Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Xiaozhou Wang
    • Shaanxi
      • Xi'an, Shaanxi, Kina, 710018
        • Xi'an People's Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Kang Cheng, MD&PhD
    • Shandong
      • Jinan, Shandong, Kina, 250012
      • Jinan, Shandong, Kina, 250013
        • Central Hospital Affiliated to Shandong First Medical University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Rui Xu, MD &. PhD
      • Liaocheng, Shandong, Kina, 252200
        • People's Hospital of Donga County, Shandong Province
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Xiaoli Wang, MD
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina, 200025
        • Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Jianzhong Xu, MD,PhD
      • Shanghai, Shanghai Municipality, Kina, 200062
        • Shanghai Putuo District Central Hospital
        • Kontakt:
          • Junqing Gao
        • Kontakt:
        • Ledende efterforsker:
          • Zongjun Liu, MD
    • Shanxi
      • Taiyuan, Shanxi, Kina, 030001
        • The second hospital of Shanxi medical unversity
        • Ledende efterforsker:
          • Bin Yang, MD
        • Kontakt:
        • Kontakt:
    • Sichuan
      • Chengdu, Sichuan, Kina, 611130
        • Chengdu Fifth People's Hospital
        • Kontakt:
          • Mingjian Lang, MD
          • Telefonnummer: 86-028-82710681
          • E-mail: zcl628@163.com
        • Kontakt:
          • Congliang Zhou
        • Ledende efterforsker:
          • Mingjian Lang, MD
      • Chengdu, Sichuan, Kina, 610500
        • The First Affiliated Hospital of Chengdu Medical College
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Peijian Wang, MD
      • Chengdu, Sichuan, Kina, 610031
        • The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Zhen Zhang, MD
    • Tianjin Municipality
      • Tianjin, Tianjin Municipality, Kina, 300211
        • The Second Hospital of Tianjin Medical University
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Changle Liu, MD
      • Tianjin, Tianjin Municipality, Kina, 300052
        • Tianjin Medical University General Hospital,
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Dianxun Fu, MD
      • Tianjin, Tianjin Municipality, Kina, 300457
        • TEDA International Cardiovascular Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Weiqiang Chen, MM
    • Xinjiang
      • Yili Kazak Autonomous Prefecture, Xinjiang, Kina, 835000
        • Yili Kazak Autonomous Prefecture Friendship Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Wei Li, MB
    • Yunnan
      • Kunming, Yunnan, Kina, 650102
        • Fuwai Yunnan Cardiovascular Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Zihong Guo, Bachelor
    • Zhejiang

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

N/A

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patients with confirmed primary aldosteronism aged from 18 to 65 with no limits in sex

Beskrivelse

Inclusion Criteria:

  1. Aged from 18 to 65 with no limits in sex;
  2. Patients with confirmed primary aldosteronism;
  3. Patients or their legal representatives sign written informed consent approved by the ethics committee;

Exclusion Criteria:

  1. Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months;
  2. An estimated glomerular filtration rate <45 ml/min/1.73 m2, or serum creatinine >176 μmol/L;
  3. Patients who refuse adrenalectomy;
  4. Suspected of having an adrenocortical carcinoma;
  5. Allergy to contrast agent;
  6. Pregnant, nursing, or planning to become pregnant

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: OTHER

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Adrenal Venous Sampling

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The success rate of bilateral adrenal venous sampling
Tidsramme: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The success rate of left adrenal venous sampling
Tidsramme: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of right adrenal venous sampling
Tidsramme: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
Selection of intraoperative catheter
Tidsramme: At AVS procedure

Types of catheter at the time of Adrenal Venous Sampling via antecubital approach or femoral approach

At AVS procedure
Time of the procedure
Tidsramme: At AVS procedure

Time of the procedure

At AVS procedure
Time of fluoroscopy
Tidsramme: At AVS procedure

Time of fluoroscopy

At AVS procedure
The contrast agent dosage
Tidsramme: At AVS procedure

The contrast agent dosage

At AVS procedure
the incidence of complications
Tidsramme: 1 week after AVS procedure

Complications related to adrenal vein cannulations (adrenal vein hematoma, inferior vena cava dissection, puncture site hematoma, etc)

1 week after AVS procedure
the cost of the procedure
Tidsramme: At AVS procedure

the cost of the procedure

At AVS procedure
pathological results(If the patient underwent adrenalectomy)
Tidsramme: 1 week After AVS procedure

Pathological types of primary aldosteronism(to compare the consistency between adrenal venous sampling results and histopathological results if the patients underwent adrenalectomy.)

1 week After AVS procedure

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Xiongjing Jiang, MD, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. december 2026

Primær færdiggørelse (Anslået)

31. august 2028

Studieafslutning (Anslået)

31. august 2029

Datoer for studieregistrering

Først indsendt

21. december 2023

Først indsendt, der opfyldte QC-kriterier

4. januar 2024

Først opslået (Faktiske)

5. januar 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

16. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

11. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 20231120

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .